<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34282021</PMID><DateCompleted><Year>2021</Year><Month>12</Month><Day>06</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>23</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1091-6490</ISSN><JournalIssue CitedMedium="Internet"><Volume>118</Volume><Issue>30</Issue><PubDate><Year>2021</Year><Month>Jul</Month><Day>27</Day></PubDate></JournalIssue><Title>Proceedings of the National Academy of Sciences of the United States of America</Title><ISOAbbreviation>Proc Natl Acad Sci U S A</ISOAbbreviation></Journal><ArticleTitle>Tradeoffs for a viral mutant with enhanced replication speed.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">e2105288118</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1073/pnas.2105288118</ELocationID><Abstract><AbstractText>RNA viruses exist as genetically heterogeneous populations due to high mutation rates, and many of these mutations reduce fitness and/or replication speed. However, it is unknown whether mutations can increase replication speed of a virus already well adapted to replication in cultured cells. By sequentially passaging coxsackievirus B3 in cultured cells and collecting the very earliest progeny, we selected for increased replication speed. We found that a single mutation in a viral capsid protein, VP1-F106L, was sufficient for the fast-replication phenotype. Characterization of this mutant revealed quicker genome release during entry compared to wild-type virus, highlighting a previously unappreciated infection barrier. However, this mutation also reduced capsid stability in vitro and reduced replication and pathogenesis in mice. These results reveal a tradeoff between overall replication speed and fitness. Importantly, this approach-selecting for the earliest viral progeny-could be applied to a variety of viral systems and has the potential to reveal unanticipated inefficiencies in viral replication cycles.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lanahan</LastName><ForeName>Matthew R</ForeName><Initials>MR</Initials><Identifier Source="ORCID">0000-0002-6061-9513</Identifier><AffiliationInfo><Affiliation>Department of Microbiology, University of Texas Southwestern Medical Center, Dallas, TX 75390-9048.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maples</LastName><ForeName>Robert W</ForeName><Initials>RW</Initials><Identifier Source="ORCID">0000-0002-5815-1210</Identifier><AffiliationInfo><Affiliation>Department of Microbiology, University of Texas Southwestern Medical Center, Dallas, TX 75390-9048.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pfeiffer</LastName><ForeName>Julie K</ForeName><Initials>JK</Initials><Identifier Source="ORCID">0000-0003-2973-4895</Identifier><AffiliationInfo><Affiliation>Department of Microbiology, University of Texas Southwestern Medical Center, Dallas, TX 75390-9048 julie.pfeiffer@utsouthwestern.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 AI074668</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI158351</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R37 AI074668</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 GM109776</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Proc Natl Acad Sci U S A</MedlineTA><NlmUniqueID>7505876</NlmUniqueID><ISSNLinking>0027-8424</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>156986-95-7</RegistryNumber><NameOfSubstance UI="D053633">Receptor, Interferon alpha-beta</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003001" MajorTopicYN="N">Cloning, Molecular</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029822" MajorTopicYN="N">Enterovirus B, Human</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="N">Enterovirus Infections</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006367" MajorTopicYN="N">HeLa Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018345" MajorTopicYN="N">Mice, Knockout</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053633" MajorTopicYN="N">Receptor, Interferon alpha-beta</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">capsid</Keyword><Keyword MajorTopicYN="N">coxsackievirus</Keyword><Keyword MajorTopicYN="N">fitness</Keyword><Keyword MajorTopicYN="N">replication speed</Keyword></KeywordList><CoiStatement>The authors declare no competing interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>7</Month><Day>20</Day><Hour>6</Hour><Minute>11</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>7</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>1</Month><Day>19</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34282021</ArticleId><ArticleId IdType="pmc">PMC8325337</ArticleId><ArticleId IdType="doi">10.1073/pnas.2105288118</ArticleId><ArticleId IdType="pii">2105288118</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Dixon L. M., Slow and steady wins the race: The behaviour and welfare of commercial faster growing broiler breeds compared to a commercial slower growing breed. PLoS One 15, e0231006 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7135253</ArticleId><ArticleId IdType="pubmed">32251460</ArticleId></ArticleIdList></Reference><Reference><Citation>Lynch M., Evolution of the mutation rate. Trends Genet. 26, 345&#x2013;352 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2910838</ArticleId><ArticleId IdType="pubmed">20594608</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#xe9;rez-Rodr&#xed;guez F. J., et al. ., Improving virus production through quasispecies genomic selection and molecular breeding. Sci. Rep. 6, 35962 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5093897</ArticleId><ArticleId IdType="pubmed">27808108</ArticleId></ArticleIdList></Reference><Reference><Citation>Venuti A., et al. ., Isolation and molecular cloning of a fast-growing strain of human hepatitis A virus from its double-stranded replicative form. J. Virol. 56, 579&#x2013;588 (1985).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC252615</ArticleId><ArticleId IdType="pubmed">2997478</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang D. T.-N., et al. ., Adaptation of influenza A (H7N9) virus in primary human airway epithelial cells. Sci. Rep. 7, 11300 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5595892</ArticleId><ArticleId IdType="pubmed">28900138</ArticleId></ArticleIdList></Reference><Reference><Citation>Pacheco B., et al. ., Adaptation of the human immunodeficiency virus type 1 envelope glycoproteins to new world monkey receptors. J. Virol. 82, 346&#x2013;357.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2224371</ArticleId><ArticleId IdType="pubmed">17959679</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergelson J. M., et al. ., Clinical coxsackievirus B isolates differ from laboratory strains in their interaction with two cell surface receptors. J. Infect. Dis. 175, 697&#x2013;700 (1997).</Citation><ArticleIdList><ArticleId IdType="pubmed">9041347</ArticleId></ArticleIdList></Reference><Reference><Citation>Karlin S., Mr&#xe1;zek J., Campbell A., Kaiser D., Characterizations of highly expressed genes of four fast-growing bacteria. J. Bacteriol. 183, 5025&#x2013;5040 (2001).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC95378</ArticleId><ArticleId IdType="pubmed">11489855</ArticleId></ArticleIdList></Reference><Reference><Citation>Aiyar S. E., Gaal T., Gourse R. L., rRNA promoter activity in the fast-growing bacterium Vibrio natriegens. J. Bacteriol. 184, 1349&#x2013;1358 (2002).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC134863</ArticleId><ArticleId IdType="pubmed">11844764</ArticleId></ArticleIdList></Reference><Reference><Citation>Groeneveld P., Stouthamer A. H., Westerhoff H. V., Super life&#x2014;How and why &#x2018;cell selection&#x2019; leads to the fastest-growing eukaryote. FEBS J. 276, 254&#x2013;270 (2009).</Citation><ArticleIdList><ArticleId IdType="pubmed">19087200</ArticleId></ArticleIdList></Reference><Reference><Citation>Pir P., et al. ., The genetic control of growth rate: A systems biology study in yeast. BMC Syst. Biol. 6, 4 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3398284</ArticleId><ArticleId IdType="pubmed">22244311</ArticleId></ArticleIdList></Reference><Reference><Citation>Furio V., Moya A., Sanjuan R., The cost of replication fidelity in an RNA virus. Proc. Natl. Acad. Sci. U.S.A. 102, 10233&#x2013;10237 (2005).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1177365</ArticleId><ArticleId IdType="pubmed">16006529</ArticleId></ArticleIdList></Reference><Reference><Citation>Border&#xed;a A. V., Rozen-Gagnon K., Vignuzzi M., &#x201c;Fidelity Variants and RNA Quasispecies&#x201d; in Quasispecies: From Theory to Experimental Systems, Domingo E., Schuster P., Eds. (Current Topics in Microbiology and Immunology, 2015), pp. 303&#x2013;322.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7121553</ArticleId><ArticleId IdType="pubmed">26499340</ArticleId></ArticleIdList></Reference><Reference><Citation>Domingo E., Holland J. J., RNA virus mutations and fitness for survival. Annu. Rev. Microbiol. 51, 151&#x2013;178 (1997).</Citation><ArticleIdList><ArticleId IdType="pubmed">9343347</ArticleId></ArticleIdList></Reference><Reference><Citation>Gn&#xe4;dig N. F., et al. ., Coxsackievirus B3 mutator strains are attenuated in vivo. Proc. Natl. Acad. Sci. U.S.A. 109, E2294&#x2013;E2303 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3427060</ArticleId><ArticleId IdType="pubmed">22853955</ArticleId></ArticleIdList></Reference><Reference><Citation>Crotty S., Cameron C. E., Andino R., RNA virus error catastrophe: Direct molecular test by using ribavirin. Proc. Natl. Acad. Sci. U.S.A. 98, 6895&#x2013;6900 (2001).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC34449</ArticleId><ArticleId IdType="pubmed">11371613</ArticleId></ArticleIdList></Reference><Reference><Citation>McDonald S., et al. ., Design of a genetically stable high fidelity coxsackievirus B3 polymerase that attenuates virus growth in vivo. J. Biol. Chem. 291, 13999&#x2013;14011 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4933160</ArticleId><ArticleId IdType="pubmed">27137934</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfeiffer J. K., Kirkegaard K., Increased fidelity reduces poliovirus fitness and virulence under selective pressure in mice. PLoS Pathog. 1, e11 (2005).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1250929</ArticleId><ArticleId IdType="pubmed">16220146</ArticleId></ArticleIdList></Reference><Reference><Citation>Vignuzzi M., Stone J. K., Arnold J. J., Cameron C. E., Andino R., Quasispecies diversity determines pathogenesis through cooperative interactions in a viral population. Nature 439, 344&#x2013;348 (2006).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1569948</ArticleId><ArticleId IdType="pubmed">16327776</ArticleId></ArticleIdList></Reference><Reference><Citation>Regoes R. R., Hamblin S., Tanaka M. M., Viral mutation rates: Modelling the roles of within-host viral dynamics and the trade-off between replication fidelity and speed. Proc. Biol. Sci. 280, 20122047 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3574426</ArticleId><ArticleId IdType="pubmed">23135674</ArticleId></ArticleIdList></Reference><Reference><Citation>Fitzsimmons W. J., et al. ., A speed-fidelity trade-off determines the mutation rate and virulence of an RNA virus. PLoS Biol. 16, e2006459 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6040757</ArticleId><ArticleId IdType="pubmed">29953453</ArticleId></ArticleIdList></Reference><Reference><Citation>Strikas R. A., Anderson L. J., Parker R. A., Temporal and geographic patterns of isolates of nonpolio enterovirus in the United States, 1970-1983. J. Infect. Dis. 153, 346&#x2013;351 (1986).</Citation><ArticleIdList><ArticleId IdType="pubmed">3003207</ArticleId></ArticleIdList></Reference><Reference><Citation>Coyne C. B., Shen L., Turner J. R., Bergelson J. M., Coxsackievirus entry across epithelial tight junctions requires occludin and the small GTPases Rab34 and Rab5. Cell Host Microbe 2, 181&#x2013;192 (2007).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2719558</ArticleId><ArticleId IdType="pubmed">18005733</ArticleId></ArticleIdList></Reference><Reference><Citation>Coyne C. B., Bergelson J. M., Virus-induced Abl and Fyn kinase signals permit coxsackievirus entry through epithelial tight junctions. Cell 124, 119&#x2013;131 (2006).</Citation><ArticleIdList><ArticleId IdType="pubmed">16413486</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung S.-K., et al. ., Internalization and trafficking mechanisms of coxsackievirus B3 in HeLa cells. Virology 333, 31&#x2013;40 (2005).</Citation><ArticleIdList><ArticleId IdType="pubmed">15708590</ArticleId></ArticleIdList></Reference><Reference><Citation>Zautner A. E., Jahn B., Hammerschmidt E., Wutzler P., Schmidtke M., N- and 6-O-sulfated heparan sulfates mediate internalization of coxsackievirus B3 variant PD into CHO-K1 cells. J. Virol. 80, 6629&#x2013;6636 (2006).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1488958</ArticleId><ArticleId IdType="pubmed">16775350</ArticleId></ArticleIdList></Reference><Reference><Citation>Zautner A. E., K&#xf6;rner U., Henke A., Badorff C., Schmidtke M., Heparan sulfates and coxsackievirus-adenovirus receptor: Each one mediates coxsackievirus B3 PD infection. J. Virol. 77, 10071&#x2013;10077 (2003).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC224569</ArticleId><ArticleId IdType="pubmed">12941917</ArticleId></ArticleIdList></Reference><Reference><Citation>Melnick J. L., Ledinko N., Immunological reactions of the Coxsackie viruses. I. The neutralization test; technic and application. J. Exp. Med. 92, 463&#x2013;482 (1950).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2135988</ArticleId><ArticleId IdType="pubmed">14778925</ArticleId></ArticleIdList></Reference><Reference><Citation>Woodruff J. F., Kilbourne E. D., The influence of quantitated post-weaning undernutrition on coxsackievirus B3 infection of adult mice. I. Viral persistence and increased severity of lesions. J. Infect. Dis. 121, 137&#x2013;163 (1970).</Citation><ArticleIdList><ArticleId IdType="pubmed">5414398</ArticleId></ArticleIdList></Reference><Reference><Citation>Knowlton K. U., Jeon E. S., Berkley N., Wessely R., Huber S., A mutation in the puff region of VP2 attenuates the myocarditic phenotype of an infectious cDNA of the Woodruff variant of coxsackievirus B3. J. Virol. 70, 7811&#x2013;7818 (1996).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC190851</ArticleId><ArticleId IdType="pubmed">8892902</ArticleId></ArticleIdList></Reference><Reference><Citation>Novella I. S., et al. ., Exponential increases of RNA virus fitness during large population transmissions. Proc. Natl. Acad. Sci. U.S.A. 92, 5841&#x2013;5844 (1995).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC41597</ArticleId><ArticleId IdType="pubmed">7597039</ArticleId></ArticleIdList></Reference><Reference><Citation>Cervera H., Elena S. F., Genetic variation in fitness within a clonal population of a plant RNA virus. Virus Evol. 2, vew006 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4989883</ArticleId><ArticleId IdType="pubmed">27774299</ArticleId></ArticleIdList></Reference><Reference><Citation>Duarte E. A., et al. ., Subclonal components of consensus fitness in an RNA virus clone. J. Virol. 68, 4295&#x2013;4301 (1994).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC236352</ArticleId><ArticleId IdType="pubmed">8207804</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuss S. K., Etheredge C. A., Pfeiffer J. K., Multiple host barriers restrict poliovirus trafficking in mice. PLoS Pathog. 4, e1000082 (2008).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2390757</ArticleId><ArticleId IdType="pubmed">18535656</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith T. J., et al. ., The site of attachment in human rhinovirus 14 for antiviral agents that inhibit uncoating. Science 233, 1286&#x2013;1293 (1986).</Citation><ArticleIdList><ArticleId IdType="pubmed">3018924</ArticleId></ArticleIdList></Reference><Reference><Citation>McKinlay M. A., Pevear D. C., Rossmann M. G., Treatment of the picornavirus common cold by inhibitors of viral uncoating and attachment. Annu. Rev. Microbiol. 46, 635&#x2013;654 (1992).</Citation><ArticleIdList><ArticleId IdType="pubmed">1332585</ArticleId></ArticleIdList></Reference><Reference><Citation>Groarke J. M., Pevear D. C., Attenuated virulence of pleconaril-resistant coxsackievirus B3 variants. J. Infect. Dis. 179, 1538&#x2013;1541 (1999).</Citation><ArticleIdList><ArticleId IdType="pubmed">10228078</ArticleId></ArticleIdList></Reference><Reference><Citation>Heinz B. A., et al. ., Genetic and molecular analyses of spontaneous mutants of human rhinovirus 14 that are resistant to an antiviral compound. J. Virol. 63, 2476&#x2013;2485 (1989).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC250706</ArticleId><ArticleId IdType="pubmed">2542566</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui Y., et al. ., Molecular basis of Coxsackievirus A10 entry using the two-in-one attachment and uncoating receptor KRM1. Proc. Natl. Acad. Sci. U.S.A. 117, 18711&#x2013;18718 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7414063</ArticleId><ArticleId IdType="pubmed">32690697</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu L., et al. ., Structures of Coxsackievirus A10 unveil the molecular mechanisms of receptor binding and viral uncoating. Nat. Commun. 9, 4985 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6255764</ArticleId><ArticleId IdType="pubmed">30478256</ArticleId></ArticleIdList></Reference><Reference><Citation>Seitsonen J. J. T., et al. ., Structural analysis of coxsackievirus A7 reveals conformational changes associated with uncoating. J. Virol. 86, 7207&#x2013;7215 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3416324</ArticleId><ArticleId IdType="pubmed">22514349</ArticleId></ArticleIdList></Reference><Reference><Citation>Shakeel S., et al. ., Structural and functional analysis of coxsackievirus A9 integrin &#x3b1;v&#x3b2;6 binding and uncoating. J. Virol. 87, 3943&#x2013;3951 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3624221</ArticleId><ArticleId IdType="pubmed">23365426</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu L., et al. ., Cryo-EM structures reveal the molecular basis of receptor-initiated coxsackievirus uncoating. Cell Host Microbe 29, 448&#x2013;462.e5 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8310385</ArticleId><ArticleId IdType="pubmed">33539764</ArticleId></ArticleIdList></Reference><Reference><Citation>Brandenburg B., et al. ., Imaging poliovirus entry in live cells. PLoS Biol. 5, e183 (2007).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1914398</ArticleId><ArticleId IdType="pubmed">17622193</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen Y., Jesudhasan P. R., Aguilera E. R., Pfeiffer J. K., Identification and characterization of a poliovirus capsid mutant with enhanced thermal stability. J. Virol. 93, e01510-18 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6401428</ArticleId><ArticleId IdType="pubmed">30567995</ArticleId></ArticleIdList></Reference><Reference><Citation>Carson S. D., Chapman N. M., Hafenstein S., Tracy S., Variations of coxsackievirus B3 capsid primary structure, ligands, and stability are selected for in a coxsackievirus and adenovirus receptor-limited environment. J. Virol. 85, 3306&#x2013;3314 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3067837</ArticleId><ArticleId IdType="pubmed">21270163</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson C. M., Jesudhasan P. R., Pfeiffer J. K., Bacterial lipopolysaccharide binding enhances virion stability and promotes environmental fitness of an enteric virus. Cell Host Microbe 15, 36&#x2013;46 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3920179</ArticleId><ArticleId IdType="pubmed">24439896</ArticleId></ArticleIdList></Reference><Reference><Citation>Stone N. P., Demo G., Agnello E., Kelch B. A., Principles for enhancing virus capsid capacity and stability from a thermophilic virus capsid structure. Nat. Commun. 10, 4471 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6775164</ArticleId><ArticleId IdType="pubmed">31578335</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung S.-K., et al. ., Internalization and trafficking mechanisms of coxsackievirus B3 in HeLa cells. Virology 333, 31&#x2013;40 (2005).</Citation><ArticleIdList><ArticleId IdType="pubmed">15708590</ArticleId></ArticleIdList></Reference><Reference><Citation>Milstone A. M., et al. ., Interaction with coxsackievirus and adenovirus receptor, but not with decay-accelerating factor (DAF), induces A-particle formation in a DAF-binding coxsackievirus B3 isolate. J. Virol. 79, 655&#x2013;660 (2005).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC538729</ArticleId><ArticleId IdType="pubmed">15596863</ArticleId></ArticleIdList></Reference><Reference><Citation>Organtini L. J., Makhov A. M., Conway J. F., Hafenstein S., Carson S. D., Kinetic and structural analysis of coxsackievirus B3 receptor interactions and formation of the A-particle. J. Virol. 88, 5755&#x2013;5765 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4019082</ArticleId><ArticleId IdType="pubmed">24623425</ArticleId></ArticleIdList></Reference><Reference><Citation>Rihn S. J., et al. ., Extreme genetic fragility of the HIV-1 capsid. PLoS Pathog. 9, e1003461 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3688543</ArticleId><ArticleId IdType="pubmed">23818857</ArticleId></ArticleIdList></Reference><Reference><Citation>Bailey D., Thackray L. B., Goodfellow I. G., A single amino acid substitution in the murine norovirus capsid protein is sufficient for attenuation in vivo. J. Virol. 82, 7725&#x2013;7728 (2008).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2493303</ArticleId><ArticleId IdType="pubmed">18495770</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J. P., et al. ., MDA5 and MAVS mediate type I interferon responses to Coxsackie B virus. J. Virol. 84, 254&#x2013;260 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2798442</ArticleId><ArticleId IdType="pubmed">19846534</ArticleId></ArticleIdList></Reference><Reference><Citation>Negishi H., et al. ., A critical link between Toll-like receptor 3 and type II interferon signaling pathways in antiviral innate immunity. Proc. Natl. Acad. Sci. U.S.A. 105, 20446&#x2013;20451 (2008).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2629334</ArticleId><ArticleId IdType="pubmed">19074283</ArticleId></ArticleIdList></Reference><Reference><Citation>Fairweather D., et al. ., IL-12 protects against coxsackievirus B3-induced myocarditis by increasing IFN-&#x3b3; and macrophage and neutrophil populations in the heart. J. Immunol. 174, 261&#x2013;269 (2005).</Citation><ArticleIdList><ArticleId IdType="pubmed">15611248</ArticleId></ArticleIdList></Reference><Reference><Citation>Lund J. M., et al. ., Recognition of single-stranded RNA viruses by Toll-like receptor 7. Proc. Natl. Acad. Sci. U.S.A. 101, 5598&#x2013;5603 (2004).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC397437</ArticleId><ArticleId IdType="pubmed">15034168</ArticleId></ArticleIdList></Reference><Reference><Citation>Jensen S., Thomsen A. R., Sensing of RNA viruses: A review of innate immune receptors involved in recognizing RNA virus invasion. J. Virol. 86, 2900&#x2013;2910 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3302314</ArticleId><ArticleId IdType="pubmed">22258243</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J. P., et al. ., Cutting edge: Antibody-mediated TLR7-dependent recognition of viral RNA. J. Immunol. 178, 3363&#x2013;3367 (2007).</Citation><ArticleIdList><ArticleId IdType="pubmed">17339429</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., Pfeiffer J. K., Emergence of a large-plaque variant in mice infected with coxsackievirus B3. MBio 7, e00119-e16 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4817249</ArticleId><ArticleId IdType="pubmed">27025249</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuss S. K., Etheredge C. A., Pfeiffer J. K., Multiple host barriers restrict poliovirus trafficking in mice. PLoS Pathogens 4, e1000082 (2008).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2390757</ArticleId><ArticleId IdType="pubmed">18535656</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuss S. K., et al. ., Intestinal microbiota promote enteric virus replication and systemic pathogenesis. Science 334, 249&#x2013;252 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3222156</ArticleId><ArticleId IdType="pubmed">21998395</ArticleId></ArticleIdList></Reference><Reference><Citation>National Research Council , Guide for the Care and Use of Laboratory Animals (National Academies Press, Washington, DC, ed. 8, 2011).</Citation></Reference><Reference><Citation>Robinson C. M., Wang Y., Pfeiffer J. K., Sex-dependent intestinal replication of an enteric virus. J. Virol. 91, e02101&#x2013;16 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5355612</ArticleId><ArticleId IdType="pubmed">28100612</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>